ACTRN12605000356662已完成不适用
The effect of Obstructive Sleep Apnoea (OSA) and its treatment with Continuous Positive Airways Pressure (CPAP) on arterial stiffness.
Prof R Grunstein0 个研究点目标入组 30 人开始时间: 2005年9月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 21 Years 至 65 Years（—）
- 性别
- All
入选标准
- •1. BMI 40 2. Must be able to read and speak English.
排除标准
- •Clinically significant co morbidity, including any unstable cardiovascular, gastrointestinal, metabolic, pulmonary (e.g., asthma, COPD), renal, neurological, hepatic, hematologic, immunologic, endocrine, psychiatric illness and/or neoplastic disease based on Principal Investigator judgment.
研究者
相似试验
已完成
不适用
The effect of Obstructive Sleep Apnoea (OSA) and its treatment with Continuous Positive Airways Pressure (CPAP) on lipid metabolismObstructive Sleep Apnoea (OSA)Respiratory - Sleep apnoeaACTRN12605000066684Woolcock Institute of Medical Research29
尚未招募
不适用
WAVES (West Australian cardioVascular Events in obstructive Sleep apnoea)Obstructive Sleep ApneaCardiovascular - Coronary heart diseaseRespiratory - Sleep apnoeaCardiovascular diseaseACTRN12619000699167West Australian Sleep Disorders Research Institute1,960
招募中
不适用
Obstructive sleep apnoea and related symptoms studyObstructive Sleep ApnoeaMental Health - DepressionRespiratory - Sleep apnoeaDepressionACTRN12612001136897ational Health and Medical Research Council Australia360
已完成
不适用
Effects of Obstructive Sleep Apnea Treatment On Opioid-Induced Respiratory DepressiopijnsysteemObstructive Sleep Apnea10046304NL-OMON41933Sint Antonius Ziekenhuis40
已完成
2 期
Obstructive Sleep Apnea and Telomere LengthObstructive Sleep ApneaNCT04872816Associação Fundo de Incentivo à Pesquisa46